The effect of type of vaginal insert and dose of pLH on embryo production, following fixed-time AI in a progestin-based superstimulatory protocol in Nelore cattle
Contribuinte(s) |
Universidade Estadual Paulista (UNESP) |
---|---|
Data(s) |
27/05/2014
27/05/2014
01/02/2007
|
Resumo |
The objective was to analyze and report field data focusing on the effect of type of progesterone-releasing vaginal insert and dose of pLH on embryo production, following a superstimulatory protocol involving fixed-time artificial insemination (FTAI) in Nelore cattle (Bos taurus indicus). Donor heifers and cows (n = 68; 136 superstimulations over 2 years) received an intravaginal, progesterone-releasing insert (CIDR® or DIB®, with 1.9 or 1.0 g progesterone, respectively) and 3-4 mg of estradiol benzoate (EB) i.m. at random stages of the estrous cycle. Five days later (designated Day 0), cattle were superstimulated with a total of 120-200 mg of pFSH (Folltropin-V®), given twice daily in decreasing doses from Days 0 to 3. All cattle received two luteolytic doses of PGF2α at 08:00 and 20:00 h on Day 2 and progesterone inserts were removed at 20:00 h on Day 3 (36 h after the first PGF2α injection). Ovulation was induced with pLH (Lutropin-V®, 12.5 or 25 mg, i.m.) at 08:00 h on Day 4 with FTAI 12, 24 and in several cases, 36 h later. Embryos were recovered on Days 11 or 12, graded and transferred to synchronous recipients. Overall, the mean (±S.E.M.) number of total ova/embryos (13.3 ± 0.8) and viable embryos (9.4 ± 0.6) and pregnancy rate (43.5%; 528/1213) did not differ among groups, but embryo viability rate (overall, 70.8%) was higher in donors with a DIB (72.3%) than a CIDR (68.3%, P = 0.007). In conclusion, the administration of pLH 12 h after progesterone removal in a progestin-based superstimulatory protocol facilitated fixed-time AI in Nelore donors, with embryo production, embryo viability and pregnancy rates after embryo transfer, comparable to published results where estrus detection and AI was done. Results suggested a possible alternative, which would eliminate the need for estrus detection in donors. © 2006 Elsevier Inc. All rights reserved. |
Formato |
655-660 |
Identificador |
http://dx.doi.org/10.1016/j.theriogenology.2006.10.001 Theriogenology, v. 67, n. 3, p. 655-660, 2007. 0093-691X http://hdl.handle.net/11449/69517 10.1016/j.theriogenology.2006.10.001 2-s2.0-33845975681 |
Idioma(s) |
eng |
Relação |
Theriogenology |
Direitos |
closedAccess |
Palavras-Chave | #Bovine #Embryo transfer #pLH #Progesterone #Superovulation #gestagen #hormone #luteinizing hormone #animal #animal disease #artificial insemination #cattle #clinical trial #drug effect #embryo (anatomy) #female #intravaginal drug administration #methodology #ovulation induction #physiology #pregnancy #pregnancy rate #reproduction #Administration, Intravaginal #Animals #Cattle #Embryo, Mammalian #Female #Hormones #Insemination, Artificial #Luteinizing Hormone #Ovulation Induction #Pregnancy #Pregnancy Rate #Progestins #Reproduction #Bos indicus #Bos taurus |
Tipo |
info:eu-repo/semantics/article |